CARRIE YAMAMOTO: Open Payments
NPI 1174908826 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 21 payments from 10 companies in 2025. Trend: 2023 $126 · 2024 $641 · 2025 $605
Food & beverage: $480Education: $125
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 9 | $308 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
Products named: XYWAV, LUMRYZ, MYFEMBREE, INSPIRE, Sunosi, REXULTI, OFEV, MOUNJARO.
Industry payments across NV — which companies pay providers there.
